Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
News Desk 2018
(Total Views: 104)
Posted On: 08/21/2018 10:15:02 AM
Post# of 617763
Avatar
Posted By: News Desk 2018
Wound Management Technologies, Inc. (WNDM: OTCQB) | WNDM Medical Inc. Announces the Publication of an Unsponsored, Prospective, Randomized, Controlled, Clinical Trial That Demonstrated the Clinical Benefits of CellerateRX(R) Surgical Activated Collagen(R) Peptides

(0)
(0)








  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site